Biotech Values

[srsmgja]

<< all these new MS treatment options is great news for patients. >>


Only one problem, Cladribine and FTY720 are very unlikely to get to market, IMO. To be sure, they will never get to the market within the 2010-2011 time frame.

Fty720 - the drug that keeps on giving........... new AE's almost every day. Yesterday we heard about another death in which investigators can't disprove a link to FTY720.

Today Citi analyst reports that the TRANSFORMS trial reported yet another case of skin cancer and 4 CASES of BREST CANCER.

But no matter, the FDA's not going to concerned about these too numerous to mention AEs...... for as soon as the FDA sees those NVS nametags and hears that magical word (ORAL), all safety bars will come tumbling down.


Yours truly,

A confirmed, extremely biased, tysabri bull